Will Competition Cause Teva Pharmaceutical Industries ltd. To Tumble? – Motley Fool


Motley Fool
Will Competition Cause Teva Pharmaceutical Industries ltd. To Tumble?
Motley Fool
Last month, the Food and Drug Administration gave the go-ahead to Novartis’ (NYSE: NVS ) and Momenta Pharmaceuticals‘ (NASDAQ: MNTA ) Glatopa, a drug for the treatment of multiple sclerosis that matches up similarly to Teva Pharmaceuticals (NYSE: …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd